Nordic Nanovector ASA NRNVF:OTCPK

RT Quote | Exchange | USD
Last | 10/15/20 EST
1.64UNCH (UNCH)
52 week range
1.64 - 1.64

...

Loading . . .

KEY STATS

  • Open0.00
  • Day High0.00
  • Day Low0.00
  • Prev Close1.64
  • 52 Week High1.64
  • 52 Week High Date10/16/20
  • 52 Week Low1.64
  • 52 Week Low Date10/16/20
  • Market Cap219.23M
  • Shares Out79.82M
  • 10 Day Average Volume-
  • Dividend-
  • Dividend Yield-
  • Beta
  • 1 Year % Change-

RATIOS/PROFITABILITY

  • EPS (TTM)-0.70
  • P/E (TTM)-2.35
  • Fwd P/E (NTM)-
  • EBITDA (MRQ)-
  • ROE (MRQ)-
  • Revenue (MRQ)-
  • Gross Margin (MRQ)-
  • Net Margin (MRQ)-
  • Debt To Equity (MRQ)-

EVENTS

  • Earnings Date-
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest Nordic Nanovector ASA News

There is no recent news for this security.

Latest NRNVF News From Our Partners

There is no recent news for this security.

QUOTE FINDER

Profile

MORE
Nordic Nanovector ASA is a Norway-based company active in the biotechnology industry. It is engaged in the development and commercialization of targeted therapeutics for hematological cancers. Its main product candidate is Betalutin, comprising a tumor-seeking anti-CD37 antibody conjugated to a low intensity radionuclide (Lutetium 177). It is designed improve treatment of Non-Hodgkin Lymphoma (NHL) and advanced through clinical development. Additionally, the Company is...
Jan Egberts M.D.
Non-Executive Chairman
Lars Nieba
Chief Executive Officer
Marco Renoldi M.D.
Chief Operating Officer
Malene Brondberg
Chief Financial Officer
Gabriele Elbl Ph.D.
Vice President
Address
Kjelsasveien 168 B
Oslo
0884
Norway